222 related articles for article (PubMed ID: 34712045)
21. Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation.
Zhu C; Guo X; Luo L; Wu Z; Luo Z; Jiang M; Zhang J; Qin B; Shi Y; Lou Y; Qiu Y; You J
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46536-46547. PubMed ID: 31751119
[TBL] [Abstract][Full Text] [Related]
22. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
Ma X; Yang S; Zhang T; Wang S; Yang Q; Xiao Y; Shi X; Xue P; Kang Y; Liu G; Sun ZJ; Xu Z
Acta Pharm Sin B; 2022 Jan; 12(1):451-466. PubMed ID: 35127398
[TBL] [Abstract][Full Text] [Related]
23. The bovine dialysable leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death in breast cancer cells leading to long-term antitumour memory.
Reyes-Ruiz A; Calvillo-Rodriguez KM; Martínez-Torres AC; Rodríguez-Padilla C
Br J Cancer; 2021 Apr; 124(8):1398-1410. PubMed ID: 33531687
[TBL] [Abstract][Full Text] [Related]
24. Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.
Hou C; Shi S; Gao M; Ji J; Ma C; Wang T; Chen T; Liu Y; Zhong J; Zheng Y; Ye J; Ke Y
J Neurooncol; 2023 Oct; 165(1):79-90. PubMed ID: 37819535
[TBL] [Abstract][Full Text] [Related]
25. Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells.
Oliyapour Y; Dabiri S; Molavi O; Hejazi MS; Davaran S; Jafari S; Montazersaheb S
Med Oncol; 2023 Aug; 40(10):278. PubMed ID: 37624439
[TBL] [Abstract][Full Text] [Related]
26. Immunogenic cell death in cancer therapy: Present and emerging inducers.
Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
[TBL] [Abstract][Full Text] [Related]
27. PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells.
Calvillo-Rodríguez KM; Mendoza-Reveles R; Gómez-Morales L; Uscanga-Palomeque AC; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
Oncoimmunology; 2022; 11(1):2054305. PubMed ID: 35402082
[TBL] [Abstract][Full Text] [Related]
28. KCl Nanoparticles as Potential Inducer of Immunogenic Cell Death for Cancer Immunotherapy.
Huang Z; Zhang X; Luo Y; Wang Y; Zhou S
ACS Appl Bio Mater; 2023 Jun; 6(6):2404-2414. PubMed ID: 37192493
[TBL] [Abstract][Full Text] [Related]
29. Self-Assembled Immunostimulatory Tetrahedral Framework Nucleic Acid Vehicles for Tumor Chemo-immunotherapy.
Liu M; Hao L; Zhao D; Li J; Lin Y
ACS Appl Mater Interfaces; 2022 Aug; 14(34):38506-38514. PubMed ID: 35973112
[TBL] [Abstract][Full Text] [Related]
30. Immunogenic Cell Death (ICD) of Murine H22 Cells Induced by Lentinan.
Wang W; Yang X; Li C; Li Y; Wang H; Han X
Nutr Cancer; 2022; 74(2):640-649. PubMed ID: 33715541
[TBL] [Abstract][Full Text] [Related]
31. Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapy.
Li J; Zhou S; Yu J; Cai W; Yang Y; Kuang X; Liu H; He Z; Wang Y
J Control Release; 2021 Jul; 335():306-319. PubMed ID: 34081995
[TBL] [Abstract][Full Text] [Related]
32. Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo.
Sha X; Xu X; Liao S; Chen H; Rui W
Exp Cell Res; 2022 Jan; 410(1):112948. PubMed ID: 34826423
[TBL] [Abstract][Full Text] [Related]
33. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death.
Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B
Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609
[TBL] [Abstract][Full Text] [Related]
34. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
[TBL] [Abstract][Full Text] [Related]
35. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
[TBL] [Abstract][Full Text] [Related]
36. Self-immolative polymer-based immunogenic cell death inducer for regulation of redox homeostasis.
Jeon J; Yoon B; Dey A; Song SH; Li Y; Joo H; Park JH
Biomaterials; 2023 Apr; 295():122064. PubMed ID: 36827894
[TBL] [Abstract][Full Text] [Related]
37. Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells.
Di Grazia A; Laudisi F; Di Fusco D; Franzè E; Ortenzi A; Monteleone I; Monteleone G; Stolfi C
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455811
[TBL] [Abstract][Full Text] [Related]
38. Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones.
Fan F; Shen P; Ma Y; Ma W; Wu H; Liu H; An Q
J Inflamm (Lond); 2021 Jun; 18(1):23. PubMed ID: 34112202
[TBL] [Abstract][Full Text] [Related]
39. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
[TBL] [Abstract][Full Text] [Related]
40. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
